Return to search

Avidity Biosciences fetches $100 mln Series C

La Jolla, California-based Avidity Biosciences, a biotechnology company, has secured $100 million in Series C financing. RTW Investments led the round. In addition to the funding, Dr. Roderick T. Wong, a managing partner of RTW Investments, will join Avidity Biosciences’ board of directors.

Source: Press Release